US HB2332 | 2011-2012 | 112th Congress
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on June 23 2011 - 25% progression, died in committee
Action: 2011-06-24 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 23 2011 - 25% progression, died in committee
Action: 2011-06-24 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Robin Danielson Act - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to provide for the conduct or support of research on the extent to which additives in feminine hygiene products pose any risks to the health of women or the health of the children of women who use those products during or before the pregnancies involved. Requires the Director of the Centers for Disease Control and Prevention (CDC) to: (1) collect, analyze, and make available data on toxic shock syndrome, including data on the causes of such syndrome; and (2) determine the national incidence and prevalence of such syndrome.
Title
Robin Danielson Act
Sponsors
Rep. Carolyn Maloney [D-NY] | Rep. John Conyers [D-MI] | Rep. Sam Farr [D-CA] | Rep. Lynn Woolsey [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2011-06-24 | House | Referred to the Subcommittee on Health. |
2011-06-23 | House | Referred to the House Committee on Energy and Commerce. |
2011-06-23 | House | Sponsor introductory remarks on measure. (CR E1174) |
Subjects
Business records
Cancer
Child health
Government information and archives
Hazardous wastes and toxic substances
Health
Health information and medical records
Health programs administration and funding
Immunology
Infectious and parasitic diseases
Medical research
Product safety and quality
Research administration and funding
Sex and reproductive health
Women's health
Cancer
Child health
Government information and archives
Hazardous wastes and toxic substances
Health
Health information and medical records
Health programs administration and funding
Immunology
Infectious and parasitic diseases
Medical research
Product safety and quality
Research administration and funding
Sex and reproductive health
Women's health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/112th-congress/house-bill/2332/all-info |
Text | https://www.congress.gov/112/bills/hr2332/BILLS-112hr2332ih.pdf |